The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
hTERT antagonizes p53-induced apoptosis independently of telomerase activity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“…plays a critical role in cellular survival, development and functions of multiple tissues and organs (Greider and Blackburn, 1996; Lee et al., 1998). hTERT activity is repressed in normal somatic tissues, but both hTERT expression and activity are elevated in most human tumors (Kim et al., 1994).”
BackgroundVogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“…and p53-mediated transcriptional transactivation of target genes, including p21, Bax and PUMA, which regulate cell cycle arrest or apoptosis (Vogelstein et al., 2000; Vousden and Lu, 2002). p53deficient mice are highly prone to various spontaneous tumors (Donehower et al., 1992; Attardi and…”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“…sequences and plays a critical role in cellular survival, development and functions of multiple tissues and organs (Greider and Blackburn, 1996; Lee et al., 1998). hTERT activity is repressed in normal somatic tissues, but both hTERT expression and activity are elevated in most human tumors…”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 1×
“…well, for example, by overexpression of the p53 antagonist MDM2 or loss of the p14ARF protein that induces p53 in response to oncogene activation (Lowe and Sherr, 2003). p53 not only transactivates target genes but also transrepresses specific genes, including the antiapoptotic Bcl-2 gene, the…”
BackgroundTelomerase modulates expression of growth-controlling genes and enhances cell proliferation
Smith, L. L., Coller, H. A., & Roberts, J. M. (2003) · Nature Cell Biology · doi:10.1038/ncb985 · Cited by 438
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182407599 · Cited by 431
Cited by
Haendeler, J., Dröse, S., Büchner, N., Jakob, S., Altschmied, J., Goy, C., Spyridopoulos, I., Zeiher, A. M., Brandt, U., & Dimmeler, S. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185546 · Cited by 375
Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells
Fan, V. H., Au, A., Tamama, K., Littrell, R., Richardson, L. B., Wright, J. W., Wells, A., & Griffith, L. G. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0320 · Cited by 269
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Zhang, Y., Jiang, P., Ye, M., Kim, S.-H., Jiang, C., & Lü, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013621 · Cited by 257
TERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238
TERT promotes cellular and organismal survival independently of telomerase activity
Lee, J., Sung, Y. H., Cheong, C., Choi, Y. S., Jeon, H. K., Sun, W., Hahn, W. C., Ishikawa, F., & Lee, H.-W. (2008) · Oncogene · doi:10.1038/sj.onc.1211037 · Cited by 145
Metadata
- Authors
- Rahman, R., Latonen, L., & Wiman, K. G.
- Venue
- Oncogene
- Published
- 2004-12-20
- Volume
- 24
- Issue
- 8
- Pages
- 1320-1327
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2078632611
- Cited by
- 158
- References
- 10
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: hTERT antagonizes p53-induced apoptosis independently of telomerase activity. https://app.cochat.ai/papers/10.1038/sj.onc.1208232
- The paper
- Rahman, R., Latonen, L., & Wiman, K. G. (2005). hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene. https://doi.org/10.1038/sj.onc.1208232
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.